ProPhase Labs, Inc.
PRPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $20 | $20 | $20 |
| Inventory | $0 | $1 | $1 | $1 |
| Other Curr. Assets | $4 | $3 | $3 | $9 |
| Total Curr. Assets | $8 | $25 | $25 | $31 |
| Property Plant & Equip (Net) | $2 | $4 | $11 | $12 |
| Goodwill | $4 | $5 | $5 | $5 |
| Intangibles | $8 | $8 | $9 | $10 |
| Long-Term Investments | $44 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $6 |
| Total NC Assets | $58 | $17 | $26 | $33 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $66 | $42 | $51 | $63 |
| Liabilities | – | – | – | – |
| Payables | $42 | $15 | $13 | $14 |
| Short-Term Debt | $7 | $6 | $6 | $7 |
| Tax Payable | $0 | $1 | $1 | $2 |
| Deferred Revenue | $1 | $1 | $2 | $2 |
| Other Curr. Liab. | $5 | $2 | $2 | $8 |
| Total Curr. Liab. | $55 | $26 | $24 | $32 |
| LT Debt | $1 | $2 | $8 | $18 |
| Deferred Rev, NC | $1 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $5 |
| Total NC Liab. | $4 | $5 | $11 | $24 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $2 | $6 | $10 |
| Total Liabilities | $59 | $31 | $35 | $56 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$66 | -$59 | -$54 | -$58 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $73 | $71 | $70 | $66 |
| Total Equity | $7 | $11 | $16 | $7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $66 | $42 | $51 | $63 |
| Net Debt | $7 | $8 | $14 | $24 |